症例の予後改善のための,電子ビームCT,4列～320列CTを用いた循環器領域の新しい臨床診断学の開発への貢献

I went to the Stanford University Department of Radiology\u27s three-dimensional (3D) imaging laboratory from 1996 to 1999 to study a novel 3D image processing technique using electron beam computed tomography (CT). When I returned to Japan, I found that multi-slice CT had been available in daily practice since 1998. We have published a total of 152 peer-reviewed papers on diagnostic images in the field of cardiovascular disease. In 2003, when 16-slice CT was available for use in general hospitals, we successfully developed a prototype 256-slice cone-beam CT at the National Institute of Radiological Sciences. We produced several papers discussing the utilities of this prototype CT in both animal and phantom experiments, the concepts and ideas that were currently used for cardiac perfusion and myocardium characteristic study. In 2010, our paper was used as a reference in the American College of Cardiology Foundation Expert Consensus Guideline. The our current topics presented include coronary artery stenosis, coronary arterial plaques, the characteristics of the myocardium, the anatomy of structural and congenital heart disease, and the cardiac function, all using 16-320 slice CT with reduced radiation exposure in CT acquisition. Furthermore, we are now performing novel clinical CT studies combined magnetic resonance imaging (MRI), positron emission tomography, and echocardiography. Using previous image data, we analyzed an epidemiology study using CT findings to predict the occurrence of major cardiovascular adverse events over long-term follow-up periods of more than 100 months (median), one of the longest follow-up periods documented in the literature. We also need to obtain accurate diagnoses for subjects with cardiac failure or fatal arrhythmia of unknown origin, allowing them to receive specific effective therapy for their possible cardiac amyloidosis, cardiac sarcoidosis, or Fabry\u27s disease. Of course, in all CT imaging techniques used for evaluation and monitoring of cardiovascular risk

Exogenous Application of Phytohormones Promotes Growth and Regulates Expression of Wood Formation-Related Genes in <em>Populus simonii</em> × <em>P. nigra</em>

Although phytohormones are known to be important signal molecules involved in wood formation, their roles are still largely unclear. Here, Populus simonii × P. nigra seedlings were treated with different concentrations of exogenous phytohormones, indole-3-acetic acid (IAA), gibberellin (GA3), and brassinosteroid (BR), and the effects of phytohormones on growth were investigated. Next, 27 genes with known roles in wood formation were selected for qPCR analysis to determine tissue-specificity and timing of responses to phytohormone treatments. Compared to the control, most IAA, GA3, and BR concentrations significantly increased seedling height. Meanwhile, IAA induced significant seedling stem diameter and cellulose content increases that peaked at 3 and 30 mg·L−1, respectively. Significant increase in cellulose content was also observed in seedlings treated with 100 mg·L−1 GA3. Neither stem diameter nor cellulose content of seedlings were affected by BR treatment significantly, although slight effects were observed. Anatomical measurements demonstrated improved xylem, but not phloem, development in IAA- and BR-treated seedlings. Most gene expression patterns induced by IAA, GA3, and BR differed among tissues. Many IAA response genes were also regulated by GA3, while BR-induced transcription was weaker and slower in Populus than for IAA and GA3. These results reveal the roles played by phytohormones in plant growth and lay the foundation for exploring molecular regulatory mechanisms of wood formation in Populus

Wen-Dan Decoction Improves Negative Emotions in Sleep-Deprived Rats by Regulating Orexin-A and Leptin Expression

Wen-Dan Decoction (WDD), a formula of traditional Chinese medicine, has been clinically used for treating insomnia for approximately 800 years. However, the therapeutic mechanisms of WDD remain unclear. Orexin-A plays a key role in the sleep-wake cycle, while leptin function is opposite to orexin-A. Thus, orexin-A and leptin may be important factors in sleep disorders. In this study, 48 rats were divided into control, model, WDD-treated, and diazepam-treated groups. The model of insomnia was produced by sleep deprivation (SD) for 14 days. The expressions of orexin-A, leptin, and their receptors in blood serum, prefrontal cortex, and hypothalamus were detected by enzyme-linked immunosorbent assay, immunohistochemistry, and real time PCR. Open field tests showed that SD increased both crossing movement (Cm) and rearing-movement (Rm) times. Orexin-A and leptin levels in blood serum increased after SD but decreased in brain compared to the control group. mRNA expressions of orexin receptor 1 and leptin receptor after SD were decreased in the prefrontal cortex but were increased in hypothalamus. WDD treatment normalized the behavior and upregulated orexin-A, leptin, orexin receptor 1 and leptin receptor in brain. The findings suggest that WDD treatment may regulate SD-induced negative emotions by regulating orexin-A and leptin expression

Resemblance of symptoms for major depression assessed at interview versus from hospital record review.

BACKGROUND: Diagnostic information for psychiatric research often depends on both clinical interviews and medical records. Although discrepancies between these two sources are well known, there have been few studies into the degree and origins of inconsistencies. PRINCIPAL FINDINGS: We compared data from structured interviews and medical records on 1,970 Han Chinese women with recurrent DSM-IV major depression (MD). Correlations were high for age at onset of MD (0.93) and number of episodes (0.70), intermediate for family history (+0.62) and duration of longest episode (+0.43) and variable but generally more modest for individual depressive symptoms (mean kappa = 0.32). Four factors were identified for twelve symptoms from medical records and the same four factors emerged from analysis of structured interviews. Factor congruencies were high but the correlation of factors between interviews and records were modest (i.e. +0.2 to +0.4). CONCLUSIONS: Structured interviews and medical records are highly concordant for age of onset, and the number and length of episodes, but agree more modestly for individual symptoms and symptom factors. The modesty of these correlations probably arises from multiple factors including i) inconsistency in the definition of the worst episode, ii) inaccuracies in self-report and iii) difficulties in coding medical records where symptoms were recorded solely for clinical purposes

Factor Loadings obtained from analysis of 12 major depression symptoms from medical records.

<p>Factor Loadings obtained from analysis of 12 major depression symptoms from medical records.</p

Correlation between information obtained from a structured interview and medical records for major depression onset and episodes.

<p>The table gives the mean, the standard deviation and the range for age in years of onset of major depression, the duration of the longest episode (in weeks) and the total number of episodes. The final two columns give the total number of observations (n), the Pearson correlation coefficient (r), and the intraclass correlation coefficient (icc).</p

The relationship between information obtained from interviews and medical records for three features of major depression.

<p>Each graph plots data from interview data on the horizontal axis against data from medical records on the vertical axis; a) the age of onset (in years) b) the number of episodes c) the duration of the longest episode of major depression (in weeks).</p